STOCK TITAN

[Form 4] Cass Information Systems Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

The Form 144 filing discloses that Brian M. Brown Revocable Trust intends to sell 35,000 AvePoint, Inc. (AVPT) common shares through Rockefeller Financial on or about April 23 2025. The proposed sale is valued at approximately $637,000, based on the market price at the time of filing. AvePoint has 203,198,202 shares outstanding, so the transaction represents roughly 0.017 % of the public float.

The trust has already sold 105,000 shares over the past three months on 03/24/2025, 04/23/2025, and 05/23/2025, generating aggregate gross proceeds of about $1.70 million. The shares being sold were originally acquired via several restricted-stock grants between July 2022 and June 2024 and are being disposed of as compensation-based holdings.

No additional financial metrics, company guidance, or operational updates are included in this filing; it is strictly a notice of a planned insider sale. Given the small percentage relative to shares outstanding, the filing is likely to be immaterial to AvePoint’s overall valuation, but it may still be monitored by investors as part of broader insider-trading trends.

Il modulo 144 rivela che il Brian M. Brown Revocable Trust intende vendere circa 35.000 azioni ordinarie di AvePoint, Inc. (AVPT) tramite Rockefeller Financial intorno al 23 aprile 2025. La vendita proposta ha un valore approssimativo di 637.000 dollari, basato sul prezzo di mercato al momento della presentazione. AvePoint conta 203.198.202 azioni in circolazione, quindi la transazione rappresenta circa lo 0,017% del flottante pubblico.

Il trust ha già venduto 105.000 azioni negli ultimi tre mesi, rispettivamente il 24/03/2025, 23/04/2025 e 23/05/2025, generando proventi lordi complessivi di circa 1,7 milioni di dollari. Le azioni vendute sono state originariamente acquisite tramite diversi conferimenti di azioni vincolate tra luglio 2022 e giugno 2024 e vengono cedute come posizioni derivanti da compensi.

Nel documento non sono inclusi ulteriori dati finanziari, previsioni aziendali o aggiornamenti operativi; si tratta esclusivamente di un avviso di una vendita interna pianificata. Considerata la percentuale ridotta rispetto alle azioni in circolazione, la comunicazione è probabilmente irrilevante per la valutazione complessiva di AvePoint, ma potrebbe comunque essere seguita dagli investitori nell’ambito delle tendenze più ampie delle negoziazioni interne.

La presentación del Formulario 144 revela que el Brian M. Brown Revocable Trust tiene la intención de vender 35,000 acciones ordinarias de AvePoint, Inc. (AVPT) a través de Rockefeller Financial alrededor del 23 de abril de 2025. La venta propuesta tiene un valor aproximado de $637,000, basado en el precio de mercado al momento de la presentación. AvePoint tiene 203,198,202 acciones en circulación, por lo que la transacción representa aproximadamente el 0.017% del flotante público.

El fideicomiso ya ha vendido 105,000 acciones en los últimos tres meses, el 24/03/2025, 23/04/2025 y 23/05/2025, generando ingresos brutos totales de aproximadamente $1.7 millones. Las acciones que se venden fueron adquiridas originalmente mediante varias concesiones de acciones restringidas entre julio de 2022 y junio de 2024, y se están disponiendo como tenencias basadas en compensación.

No se incluyen métricas financieras adicionales, orientación de la empresa ni actualizaciones operativas en esta presentación; es estrictamente un aviso de una venta interna planificada. Dada la pequeña proporción en relación con las acciones en circulación, la presentación probablemente sea irrelevante para la valoración general de AvePoint, pero aún puede ser monitoreada por los inversores como parte de tendencias más amplias de operaciones internas.

Form 144 제출 서류에 따르면 Brian M. Brown Revocable Trust2025년 4월 23일경 Rockefeller Financial을 통해 AvePoint, Inc. (AVPT)의 보통주 35,000주를 매도할 예정입니다. 제출 시점의 시장 가격을 기준으로 이번 매도 가치는 약 637,000달러로 평가됩니다. AvePoint는 203,198,202주의 발행 주식을 보유하고 있어, 이번 거래는 공개 유통 주식의 약 0.017%에 해당합니다.

이 신탁은 이미 지난 3개월 동안 03/24/2025, 04/23/2025, 05/23/2025에 걸쳐 105,000주를 매도하여 총 약 170만 달러의 총수익을 창출했습니다. 매도되는 주식은 2022년 7월부터 2024년 6월 사이에 여러 차례 제한 주식 부여를 통해 취득한 것으로, 보상 기반 보유 주식으로 처분되고 있습니다.

이번 제출 서류에는 추가적인 재무 지표, 회사 가이던스 또는 운영 업데이트가 포함되어 있지 않으며, 단지 계획된 내부자 매도에 관한 통지일 뿐입니다. 발행 주식 대비 적은 비율임을 고려할 때, 이번 제출은 AvePoint 전체 가치 평가에 중대한 영향을 미치지 않을 가능성이 크지만, 투자자들은 내부자 거래 추세의 일환으로 주시할 수 있습니다.

Le dépôt du formulaire 144 révèle que le Brian M. Brown Revocable Trust prévoit de vendre environ 35 000 actions ordinaires d’AvePoint, Inc. (AVPT) via Rockefeller Financial aux alentours du 23 avril 2025. La vente proposée est évaluée à environ 637 000 dollars, selon le cours du marché au moment du dépôt. AvePoint compte 203 198 202 actions en circulation, ce qui fait que la transaction représente environ 0,017% du flottant public.

Le trust a déjà vendu 105 000 actions au cours des trois derniers mois, les 24/03/2025, 23/04/2025 et 23/05/2025, générant un produit brut total d’environ 1,7 million de dollars. Les actions vendues ont été initialement acquises via plusieurs attributions d’actions restreintes entre juillet 2022 et juin 2024 et sont cédées en tant que titres liés à la rémunération.

Ce dépôt ne contient aucune métrique financière supplémentaire, aucune orientation de la société ni mise à jour opérationnelle ; il s’agit strictement d’un avis de vente prévue par un initié. Étant donné la faible proportion par rapport aux actions en circulation, ce dépôt est probablement sans incidence sur la valorisation globale d’AvePoint, mais il pourrait néanmoins être surveillé par les investisseurs dans le cadre des tendances plus larges des transactions d’initiés.

Die Form 144-Meldung gibt bekannt, dass der Brian M. Brown Revocable Trust beabsichtigt, am oder um den 23. April 2025 etwa 35.000 AvePoint, Inc. (AVPT) Stammaktien über Rockefeller Financial zu verkaufen. Der vorgeschlagene Verkauf hat einen Wert von ungefähr 637.000 US-Dollar, basierend auf dem Marktpreis zum Zeitpunkt der Meldung. AvePoint hat 203.198.202 ausstehende Aktien, sodass die Transaktion etwa 0,017% des Streubesitzes ausmacht.

Der Trust hat bereits in den letzten drei Monaten am 24.03.2025, 23.04.2025 und 23.05.2025 105.000 Aktien verkauft und dabei einen Bruttoerlös von rund 1,7 Millionen US-Dollar erzielt. Die verkauften Aktien wurden ursprünglich im Rahmen mehrerer Restricted-Stock-Zuweisungen zwischen Juli 2022 und Juni 2024 erworben und werden als vergütungsbasierte Bestände veräußert.

Die Meldung enthält keine weiteren finanziellen Kennzahlen, Unternehmensprognosen oder operative Updates; sie dient ausschließlich als Mitteilung über einen geplanten Insider-Verkauf. Angesichts des geringen Anteils im Verhältnis zu den ausstehenden Aktien ist die Meldung wahrscheinlich unwesentlich für die Gesamtbewertung von AvePoint, könnte aber dennoch von Investoren im Rahmen breiterer Insider-Handelstrends beobachtet werden.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider trust plans modest sale—only 0.017% of float—continuing recent selling trend; limited standalone impact.

Insider activity can signal sentiment, but this filing covers just 35,000 shares against a >203 million share base. The same trust has sold 105,000 shares in the prior quarter, suggesting a personal diversification program rather than a material shift in outlook. There is no accompanying negative disclosure, and the seller affirms no undisclosed adverse information under Rule 144. Overall, I classify the impact as neutral; the volume is too small to pressure the stock, though continuous sales may weigh on perception marginally.

TL;DR: Routine Rule 144 filing; size immaterial, watch only if selling accelerates.

From a portfolio standpoint, 35 k shares worth $0.64 mm will neither influence liquidity nor pricing for AVPT (average daily volume far exceeds this). The insider’s cumulative quarterly disposal of 140 k shares remains de-minimis. Unless this pattern escalates or aligns with deteriorating fundamentals, I regard the notice as not impactful to investment theses.

Il modulo 144 rivela che il Brian M. Brown Revocable Trust intende vendere circa 35.000 azioni ordinarie di AvePoint, Inc. (AVPT) tramite Rockefeller Financial intorno al 23 aprile 2025. La vendita proposta ha un valore approssimativo di 637.000 dollari, basato sul prezzo di mercato al momento della presentazione. AvePoint conta 203.198.202 azioni in circolazione, quindi la transazione rappresenta circa lo 0,017% del flottante pubblico.

Il trust ha già venduto 105.000 azioni negli ultimi tre mesi, rispettivamente il 24/03/2025, 23/04/2025 e 23/05/2025, generando proventi lordi complessivi di circa 1,7 milioni di dollari. Le azioni vendute sono state originariamente acquisite tramite diversi conferimenti di azioni vincolate tra luglio 2022 e giugno 2024 e vengono cedute come posizioni derivanti da compensi.

Nel documento non sono inclusi ulteriori dati finanziari, previsioni aziendali o aggiornamenti operativi; si tratta esclusivamente di un avviso di una vendita interna pianificata. Considerata la percentuale ridotta rispetto alle azioni in circolazione, la comunicazione è probabilmente irrilevante per la valutazione complessiva di AvePoint, ma potrebbe comunque essere seguita dagli investitori nell’ambito delle tendenze più ampie delle negoziazioni interne.

La presentación del Formulario 144 revela que el Brian M. Brown Revocable Trust tiene la intención de vender 35,000 acciones ordinarias de AvePoint, Inc. (AVPT) a través de Rockefeller Financial alrededor del 23 de abril de 2025. La venta propuesta tiene un valor aproximado de $637,000, basado en el precio de mercado al momento de la presentación. AvePoint tiene 203,198,202 acciones en circulación, por lo que la transacción representa aproximadamente el 0.017% del flotante público.

El fideicomiso ya ha vendido 105,000 acciones en los últimos tres meses, el 24/03/2025, 23/04/2025 y 23/05/2025, generando ingresos brutos totales de aproximadamente $1.7 millones. Las acciones que se venden fueron adquiridas originalmente mediante varias concesiones de acciones restringidas entre julio de 2022 y junio de 2024, y se están disponiendo como tenencias basadas en compensación.

No se incluyen métricas financieras adicionales, orientación de la empresa ni actualizaciones operativas en esta presentación; es estrictamente un aviso de una venta interna planificada. Dada la pequeña proporción en relación con las acciones en circulación, la presentación probablemente sea irrelevante para la valoración general de AvePoint, pero aún puede ser monitoreada por los inversores como parte de tendencias más amplias de operaciones internas.

Form 144 제출 서류에 따르면 Brian M. Brown Revocable Trust2025년 4월 23일경 Rockefeller Financial을 통해 AvePoint, Inc. (AVPT)의 보통주 35,000주를 매도할 예정입니다. 제출 시점의 시장 가격을 기준으로 이번 매도 가치는 약 637,000달러로 평가됩니다. AvePoint는 203,198,202주의 발행 주식을 보유하고 있어, 이번 거래는 공개 유통 주식의 약 0.017%에 해당합니다.

이 신탁은 이미 지난 3개월 동안 03/24/2025, 04/23/2025, 05/23/2025에 걸쳐 105,000주를 매도하여 총 약 170만 달러의 총수익을 창출했습니다. 매도되는 주식은 2022년 7월부터 2024년 6월 사이에 여러 차례 제한 주식 부여를 통해 취득한 것으로, 보상 기반 보유 주식으로 처분되고 있습니다.

이번 제출 서류에는 추가적인 재무 지표, 회사 가이던스 또는 운영 업데이트가 포함되어 있지 않으며, 단지 계획된 내부자 매도에 관한 통지일 뿐입니다. 발행 주식 대비 적은 비율임을 고려할 때, 이번 제출은 AvePoint 전체 가치 평가에 중대한 영향을 미치지 않을 가능성이 크지만, 투자자들은 내부자 거래 추세의 일환으로 주시할 수 있습니다.

Le dépôt du formulaire 144 révèle que le Brian M. Brown Revocable Trust prévoit de vendre environ 35 000 actions ordinaires d’AvePoint, Inc. (AVPT) via Rockefeller Financial aux alentours du 23 avril 2025. La vente proposée est évaluée à environ 637 000 dollars, selon le cours du marché au moment du dépôt. AvePoint compte 203 198 202 actions en circulation, ce qui fait que la transaction représente environ 0,017% du flottant public.

Le trust a déjà vendu 105 000 actions au cours des trois derniers mois, les 24/03/2025, 23/04/2025 et 23/05/2025, générant un produit brut total d’environ 1,7 million de dollars. Les actions vendues ont été initialement acquises via plusieurs attributions d’actions restreintes entre juillet 2022 et juin 2024 et sont cédées en tant que titres liés à la rémunération.

Ce dépôt ne contient aucune métrique financière supplémentaire, aucune orientation de la société ni mise à jour opérationnelle ; il s’agit strictement d’un avis de vente prévue par un initié. Étant donné la faible proportion par rapport aux actions en circulation, ce dépôt est probablement sans incidence sur la valorisation globale d’AvePoint, mais il pourrait néanmoins être surveillé par les investisseurs dans le cadre des tendances plus larges des transactions d’initiés.

Die Form 144-Meldung gibt bekannt, dass der Brian M. Brown Revocable Trust beabsichtigt, am oder um den 23. April 2025 etwa 35.000 AvePoint, Inc. (AVPT) Stammaktien über Rockefeller Financial zu verkaufen. Der vorgeschlagene Verkauf hat einen Wert von ungefähr 637.000 US-Dollar, basierend auf dem Marktpreis zum Zeitpunkt der Meldung. AvePoint hat 203.198.202 ausstehende Aktien, sodass die Transaktion etwa 0,017% des Streubesitzes ausmacht.

Der Trust hat bereits in den letzten drei Monaten am 24.03.2025, 23.04.2025 und 23.05.2025 105.000 Aktien verkauft und dabei einen Bruttoerlös von rund 1,7 Millionen US-Dollar erzielt. Die verkauften Aktien wurden ursprünglich im Rahmen mehrerer Restricted-Stock-Zuweisungen zwischen Juli 2022 und Juni 2024 erworben und werden als vergütungsbasierte Bestände veräußert.

Die Meldung enthält keine weiteren finanziellen Kennzahlen, Unternehmensprognosen oder operative Updates; sie dient ausschließlich als Mitteilung über einen geplanten Insider-Verkauf. Angesichts des geringen Anteils im Verhältnis zu den ausstehenden Aktien ist die Meldung wahrscheinlich unwesentlich für die Gesamtbewertung von AvePoint, könnte aber dennoch von Investoren im Rahmen breiterer Insider-Handelstrends beobachtet werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RUPP JOSEPH D

(Last) (First) (Middle)
12444 POWERSCOURT DR
SUITE 550

(Street)
ST. LOUIS MO 63131

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CASS INFORMATION SYSTEMS INC [ CASS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/19/2025 A 311 A $41.68 21,119(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes restricted stock bonus shares, subject to vesting and forfeiture.
Remarks:
/s/ Joseph D. Rupp 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Cass Info Sys

NASDAQ:CASS

CASS Rankings

CASS Latest News

CASS Latest SEC Filings

CASS Stock Data

572.34M
11.85M
11.02%
67.12%
1.12%
Specialty Business Services
Services-business Services, Nec
Link
United States
ST. LOUIS